Tumor-suppressor p53: Implications for tumor development and prognosis

被引:241
作者
Kirsch, DG [1 ]
Kastan, MB [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
关键词
D O I
10.1200/JCO.1998.16.9.3158
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p53 protein plays a central role in modulating cellular responses to cytotoxic stresses by contributing to both cell-cycle arrest and programmed cell death. Loss of p53 function during tumorigenesis can lead to inappropriate cell growth, increased cell survival, and genetic instability, p53 gene mutations occur in approximately half of all malignancies from a wide range of human rumors. In some tumor types, these p53 mutations are associated with poor prognosis and treatment failure, Based on these insights, new approaches are being developed to prevent diagnose, and treat cancer. J Clin Oncol 16:3158-3168. (C) 1998 by American Society of Clinical Oncology.
引用
收藏
页码:3158 / 3168
页数:11
相关论文
共 130 条
[71]   CHARACTERIZATION OF A 54K DALTON CELLULAR SV40 TUMOR-ANTIGEN PRESENT IN SV40-TRANSFORMED CELLS AND UNINFECTED EMBRYONAL CARCINOMA-CELLS [J].
LINZER, DIH ;
LEVINE, AJ .
CELL, 1979, 17 (01) :43-52
[72]  
LIU E, 1992, ONCOGENE, V7, P1027
[73]   Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c [J].
Liu, XS ;
Kim, CN ;
Yang, J ;
Jemmerson, R ;
Wang, XD .
CELL, 1996, 86 (01) :147-157
[74]   ALTERED CELL-CYCLE ARREST AND GENE AMPLIFICATION POTENTIAL ACCOMPANY LOSS OF WILD-TYPE P53 [J].
LIVINGSTONE, LR ;
WHITE, A ;
SPROUSE, J ;
LIVANOS, E ;
JACKS, T ;
TISTY, TD .
CELL, 1992, 70 (06) :923-935
[75]   P53 IS REQUIRED FOR RADIATION-INDUCED APOPTOSIS IN MOUSE THYMOCYTES [J].
LOWE, SW ;
SCHMITT, EM ;
SMITH, SW ;
OSBORNE, BA ;
JACKS, T .
NATURE, 1993, 362 (6423) :847-849
[76]   P53 STATUS AND THE EFFICACY OF CANCER-THERAPY IN-VIVO [J].
LOWE, SW ;
BODIS, S ;
MCCLATCHEY, A ;
REMINGTON, L ;
RULEY, HE ;
FISHER, DE ;
HOUSMAN, DE ;
JACKS, T .
SCIENCE, 1994, 266 (5186) :807-810
[77]   P53-DEPENDENT APOPTOSIS MODULATES THE CYTOTOXICITY OF ANTICANCER AGENTS [J].
LOWE, SW ;
RULEY, HE ;
JACKS, T ;
HOUSMAN, DE .
CELL, 1993, 74 (06) :957-967
[78]   GERM LINE P53 MUTATIONS IN A FAMILIAL SYNDROME OF BREAST-CANCER, SARCOMAS, AND OTHER NEOPLASMS [J].
MALKIN, D ;
LI, FP ;
STRONG, LC ;
FRAUMENI, JF ;
NELSON, CE ;
KIM, DH ;
KASSEL, J ;
GRYKA, MA ;
BISCHOFF, FZ ;
TAINSKY, MA ;
FRIEND, SH .
SCIENCE, 1990, 250 (4985) :1233-1238
[79]   GERMLINE MUTATIONS OF THE P53 TUMOR-SUPPRESSOR GENE IN CHILDREN AND YOUNG-ADULTS WITH 2ND MALIGNANT NEOPLASMS [J].
MALKIN, D ;
JOLLY, KW ;
BARBIER, N ;
LOOK, AT ;
FRIEND, SH ;
GEBHARDT, MC ;
ANDERSEN, TI ;
BORRESEN, AL ;
LI, FP ;
GARBER, J ;
STRONG, LC .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (20) :1309-1315
[80]  
MALKIN D, 1994, CANCER RES, V54, P2077